共 50 条
- [35] Adverse Drug Reaction Reporting Using a Mobile Device Application by Persons with Multiple Sclerosis: A Cluster Randomized Controlled Trial Drug Safety, 2021, 44 : 223 - 233
- [38] A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (09): : 899 - 910
- [40] Randomized controlled trial of physical activity, cognition, and walking in multiple sclerosis Journal of Neurology, 2014, 261 : 363 - 372